News

Filter

RegeneRx explores strategic options

02-02-2012

US biotech firm RegeneRx Biopharmaceuticals. (OTC Bulletin Board: RGRX) revealed yesterday that it has…

BiotechnologyCardio-vascularDermatologicalsLicensingNeurologicalOphthalmicsRegeneRx

Valeant continues buying spree getting rights to Cholestagel and Aczone in Canada

11-02-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) went on another shopping spree yesterday,…

Aczone GelAllerganCardio-vascularCholestagelDermatologicalsGenzymeLicensingNorth AmericaPharmaceuticalValeant Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top